SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)
14.36
-0.04 (-0.28%)
At close: Jan 30, 2026
SCHOTT Pharma AG & Co. KGaA Employees
As of September 30, 2025, SCHOTT Pharma AG & Co. KGaA had 4,811 total employees, including 4,620 full-time and 191 part-time employees. The number of employees increased by 121 or 2.58% compared to the previous year.
Employees
4,811
Change
121
Growth
2.58%
Revenue / Employee
€209,120
Profits / Employee
€31,055
Market Cap
2.16B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 4,811 | 121 | 2.58% | 4,620 | 191 |
| Jun 30, 2025 | 4,775 | 94 | 2.01% | 4,775 | 0 |
| Mar 31, 2025 | 4,790 | 118 | 2.53% | 4,790 | 0 |
| Dec 31, 2024 | 4,749 | 62 | 1.32% | 4,749 | 0 |
| Sep 30, 2024 | 4,690 | 44 | 0.95% | 4,517 | 173 |
| Jun 30, 2024 | 4,681 | 35 | 0.75% | 4,681 | 0 |
| Mar 31, 2024 | 4,672 | - | - | 4,672 | 0 |
| Dec 31, 2023 | 4,687 | 4 | 0.09% | 4,687 | 0 |
| Sep 30, 2023 | 4,646 | -37 | -0.79% | 4,479 | 167 |
| Sep 30, 2022 | 4,683 | - | - | 4,683 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Bayer Aktiengesellschaft | 88,502 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 62,346 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,784 |
| SCHOTT Pharma AG & Co. KGaA | 4,811 |
| Evotec SE | 4,788 |
SCHOTT Pharma AG & Co. KGaA News
- 6 weeks ago - EQS-DD: SCHOTT Pharma AG & Co. KGaA: Reinhard Mayer, buy - Wallstreet:Online
- 7 weeks ago - SCHOTT Pharma AG & Co. KGaA (SHTPY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - SCHOTT Pharma AG & Co. KGaA 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - SCHOTT Pharma Achieves Full-Year Revenue & Profit Targets - Wallstreet:Online
- 7 weeks ago - EQS-News: SCHOTT Pharma delivers on full-year revenue and profitability targets - Wallstreet:Online
- 2 months ago - SCHOTT Pharma Projects 5.8% Revenue Growth In 2025 - Nasdaq
- 2 months ago - SCHOTT Pharma Reports FY 2025 Results, Outlook FY 2026 & Guidance Update - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance - Wallstreet:Online